EMA Authorised: Capecitabine Accord (capecitabine) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Capecitabine Accord (capecitabine) by Accord Healthcare S.L.U. for breast cancer, colorectal cancer, and stomach cancer, with decision dated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Stomach Cancer

Drugs mentioned

• Capecitabine Accord (capecitabine)

Snippet

Status: Authorised. Therapeutic area: Colonic Neoplasms;Breast Neoplasms;Colorectal Neoplasms;Stomach Neoplasms. MAH: Accord Healthcare S.L.U.. Decision date: 04/04/2025